Regeneron Uncensored: How Decades of Investing in Innovation Powered the Rapid F

Name: Regeneron Uncensored: How Decades of Investing in Innovation Powered the Rapid F
Start: 2021-10-19T11:55:00
End: 2021-10-19T12:15:00
Location: Boston

Keep exploring for FREE!

Create a free account or log in to unlock content, event past recordings and more!

About this Session:

Developed in rapid response to the COVID-19 pandemic, Regeneron’s monoclonal antibody treatment is the result of Regeneron’s decades-long investment in scientific innovation and the creation of turnkey technologies, such as VelociSuite®. Join STAT’s Matt Herper for a behind-the-scenes conversation with George D. Yancopoulos, M.D., Ph.D., President and Chief Scientific Officer at Regeneron about how Regeneron built the scientific discovery engine that has helped fight diseases from EBOLA to COVID-19 – and the future of scientific innovation in a post-pandemic world.

Featured:

AI Vizionaries Summit: How AI is reshaping the Point of Care

Featured:

The Future of Value-Based Care: Scaling Beyond Pilots

A New Era for Employee Healthcare

Featured:

AI Vizionaries Summit: How AI is reshaping the Point of Care

The Future of Value-Based Care: Scaling Beyond Pilots

Featured:

Real-time conversations with other healthcare innovators!

Build your network by connecting with other healthcare leaders.

Featured:

How health plans can move beyond engagement volume to measurable behavior change

2025 Healthcare Wrap Up: Scribes, Jabs, and Government Grabs

HLTH 2021

How has patient centricity evolved during the pandemic?

Welcome and ATA Update

Inclusive Knowledge Creation in Healthcare

Women & COVID: The Decline of Wellbeing and Implications for Recovery

Keynote: The Lessons Learned from 2020 Provide a Springboard for Increased Teleh

AHA Welcome and Opening Remarks

Racism and Health Justice in Respiratory Disease

Panel: Conquering the Digital Divide

From AI to Blockchain and Beyond: What's the Future of Digital Health?

Story Slam: Expanding Care Sites, Improving Access to Care

Pathways to Birth Equity

Bridging the Gap Between Patients and Industry

New Opportunities for Equity in Kidney Disease

Executive Spotlight: Telehealth and HealthTech: Bridging the Gap

Overcoming Workforce Challenges to Ensure Access to Care

Achieving health equity through pharmacies

The Digital Front Door to Expanding Access

Panel: Healthcare’s Future: Evolving to a Hybrid Model of Care

Strengthening Communities as an Inroad to Equity

Progress Report: Closing Sex Gaps in Medical Research & Treatment

Story Slam: Improving Equity beyond Care Delivery

Investment trends in patient experience and engagement

Executive Spotlight: Evolution of Telehealth: New Modalities for Primary Care

More than Zip Codes: Minding the Metrics for Health Justice

Being Seen: Connecting in Mental Health

Actionable Approaches to Addressing Health Equity through SDOH

Fireside Chat: A.I.’s Role in Bias and Equity

Addressing Health Equity through Personalization

Stigma, Mistrust & Racism: Lessons Learned from HIV

Care Homes for LGBTQ+-Identified People

AHA Closing Remarks

ATA Closing Remarks

Vying for Value

(Out with the Old) In With the New Way of R&D

Adolescent Mental Health State of Emergency

Providers, Payers, Payments…Oh My

Employer’s Crucial Role in Mental & Behavioral Health

Drug Discovery’s AI Engine

Dissolving Access Barriers

Holy Primary Care!

Driving Diversity in Clinical Trials

Home-ing In on Chronic Condition Management

Is Our Future Decentralized?

Bracing for Impact: The Pandemic's Toll on Mental Illness

The Real Disruptors of Health Care

A Shared Vision For Health Assurance

What’s ahead for Google Health?

Pfizer's Next Chapter

A Lifelong Journey to Normalize Mental Wellness

Regeneron Uncensored: How Decades of Investing in Innovation Powered the Rapid F

Keep exploring for FREE!

About this Session: